Narrow your search

Library

VUB (31)

Thomas More Kempen (24)

Odisee (23)

Thomas More Mechelen (23)

UCLL (23)

VIVES (23)

LUCA School of Arts (21)

KU Leuven (18)

ULiège (18)

UGent (16)

More...

Resource type

book (31)


Language

English (31)


Year
From To Submit

2024 (1)

2023 (2)

2021 (1)

2019 (2)

2017 (4)

More...
Listing 1 - 10 of 31 << page
of 4
>>
Sort by

Book
Quality assurance and quality improvement handbook for human research
Authors: --- ---
ISBN: 1421432838 9781421432830 9781421432823 142143282X Year: 2019 Publisher: Baltimore : Johns Hopkins University Press,

Clinical trials : a methodologic perspective.
Author:
ISBN: 9780471727811 0471727814 Year: 2005 Publisher: Hoboken Wiley-Interscience

Loading...
Export citation

Choose an application

Bookmark

Abstract

Learn rigorous statistical methods to ensure valid clinical trialsThis Second Edition of the critically hailed Clinical Trials builds on the text's reputation as a straightforward and authoritative presentation of statistical methods for clinical trials. Readers are introduced to the fundamentals of design for various types of clinical trials and then skillfully guided through the complete process of planning the experiment, assembling a study cohort, assessing data, and reporting results. Throughout the process, the author alerts readers to problems that may arise during the course of


Book
New drug development : an introduction to clinical trials
Author:
ISBN: 9781441964182 9781441964175 Year: 2010 Publisher: New York : Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

New Drug Development, 2nd Edition, is a reader-friendly introduction to clinical trials that is written specifically for entry-level professionals in the pharmaceutical, biopharmaceutical, and contract research organization (CRO) industries. It is also excellent reading for seasoned clinical research professionals who wish to refresh their knowledge in areas outside their immediate fields of expertise, and for students of clinical research, pharmacy, medicine, nursing, and allied health professions. While the main focus is on preapproval clinical trials, the book adopts a lifecycle drug development approach, placing these trials in the overall continuum from drug discovery to postmarketing surveillance. It therefore contains brief discussions of medicinal chemistry, nonclinical research, drug manufacturing, and the latest techniques for gathering information concerning adverse drug reactions. This edition builds on the success of the first edition by keeping the discussions that were most helpful to readers, and adding new chapters addressing important contemporary topics in drug development. The chapters dealing with the design and analysis of clinical trials in the first edition received praise from many sources. This new edition incorporates extended discussions of the operational aspects of conducting various kinds of trials, ranging from highly specialized and relatively small cardiac safety studies to very large, multi-site Phase III trials run in several different countries.


Book
Realist trials and systematic reviews : rigorous, useful evidence to inform health policy
Authors: --- ---
ISBN: 9781009456616 100945661X 1009456628 9781009456609 Year: 2024 Publisher: Cambridge, United Kingdom ; New York, NY : Cambridge University Press,

Loading...
Export citation

Choose an application

Bookmark

Abstract

This book describes an innovative approach to the evaluation of complex health interventions, assessing what interventions work, how and for whom. Rejecting the stalemate between trials and realist evaluation, it draws on the best of both. Randomised controlled trials and systematic reviews offer the least biased means of assessing intervention effects but tell us little scientifically about how interventions work. Policy-makers and practitioners are also not supported to decide which interventions are likely to achieve most benefits in their local contexts. Realists use other forms of evaluation and evidence synthesis exploring how intervention mechanisms interact with context to generate outcomes. But these approaches lack rigour in assessing causality. This book proposes how realist evaluation methods may be incorporated within randomised controlled trials and systematic reviews. This enables evaluations and evidence synthesis to benefit from the more nuanced questions posed within realist enquiry while maintaining rigour in assessing causality.

Biostatistics in clinical trials
Authors: ---
ISBN: 0471822116 9780471822110 Year: 2001 Publisher: Chichester Wiley

Loading...
Export citation

Choose an application

Bookmark

Abstract

With exceptional contributions from an international array of leading experts in academia, government and industry, Biostatistics in Clinical Trials has been designed to complement existing texts by providing extensive, up-to-date coverage and introducing the reader to the research literature.Featuring articles from the prestigious Encyclopedia of Biostatistics, many of which have been fully revised and updated to reflect recent developments in the field, Biostatistics in Clinical Trials also includes up to 25% newly commissioned material reflecting the latest thinking in:* Bayesian methods* Benefit/risk assessment* Cost-effectiveness* Ethics and Fraud* Software* Cluster Randomization,* Guidelines (i.e. the International Committee on Harmonization),* Multiple Endpoints,* Sequential Analysis Offering a wealth of information, Biostatistics in Clinical Trials...Features an extensive and comprehensive range of topics that relate to the design, conduct, and analysis of clinical trials. In addition, articles have been included that discuss biostatistical aspects of clinical trials such as societies, textbooks, publication guides, historical perspectives, particular trials and collaborative trial groups.* Includes concise definitions and introductions to numerous concepts found in current literature* Discusses the software and textbooks available* Uses extensive cross-references helping to facilitate further research and enabling the reader to locate definitions and related concepts* Provides bibliographic citations to serve as signposts to assist researchers in further investigations of the topic An essential single volume reference for practitioners and researchers...Academics and practitioners from various disciplines and settings, such as universities, the pharmaceutical industry and clinical research organizations, will find this a comprehensive compendium of information on all aspects of clinical trials.


Book
Clinical trials and tribulations
Authors: --- ---
ISBN: 012821788X 0128217871 9780128217887 9780128217870 Year: 2023 Publisher: Kidlington, England : Academic Press,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Clinical Trials and Tribulations evaluates the multiple layers of complexities around research management, also exploring current practices, challenges and future directions. The book provides answers to readers questions and problems through extensive use of real-world examples, case studies and lessons learned. Following an approach to provide pragmatic viewpoints as well as concepts and methodologies and its alignment with specific practices, the book explores paradigms between planning and conducting research in academia vs. healthcare vs. industry in the UK vs. Europe vs. America. It highlights practical solutions to real-world complex issues that have been documented by independent regulators. This will be an indispensable book for all staff working in clinical research within healthcare, academia and industry, as well as students intending to work in clinical trials. Covers key topics across pre-clinical, clinical research and clinical practice. Highlights areas such as the socioeconomics of conducting research, capacity and capability, research quality and performance (including performance indicators, adaptive design and practical solutions); Provides lessons learned from breach of protocols, ethical breaches, SAE/SUSARs, aseptic pharmacy preparation issues, and instability within research structures ; Includes a focus on the UK clinical research system, offering key insights into working within the UK and collaborating with UK partners.


Book
Envisioning a transformed clinical trials enterprise in the United States : establishing an agenda for 2020: workshop summary
Authors: --- --- --- ---
ISBN: 0309253152 0309253160 1283636360 0309253187 9780309253154 9780309253161 Year: 2012 Publisher: Washington : National Academies Press,


Book
Pregnancy and the pharmaceutical industry : the movement towards evidence-based pharmacotherapy for pregnant women
Author:
ISBN: 0128190744 0128185503 9780128190746 9780128185506 Year: 2019 Publisher: London, England : Academic Press,

Data Monitoring in Clinical Trials : A Case Studies Approach
Authors: --- ---
ISBN: 9780387301075 9780387203300 0387203303 9786610611959 1280611952 0387301070 Year: 2006 Publisher: New York, NY : Springer New York : Imprint: Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Randomized clinical trials are the gold standard for establishing many clinical practice guidelines and are central to evidence based medicine. Obtaining the best evidence through clinical trials must be done within the boundaries of rigorous science and ethical principles. One fundamental principle is that trials should not continue longer than necessary to reach their objectives. Therefore, trials must be monitored for recruitment progress, quality of data, adherence to patient care or prevention standards, and early evidence of benefit or harm. Frequently, a group of external experts, independent from the investigators and trial sponsor, is charged with this monitoring responsibility, especially for safety and early benefit. This group is referred to by various names, such as a data monitoring committee or a data and safety monitoring board. This book, through a series of case studies presented by many distinguished clinical trial experts, illustrates the complexity of this monitoring process. The editors provide an overview of the process and a summary of a multitude of the lessons learned from the cases presented. This book should be useful to anyone serving on a data and safety monitoring board, or planning to do so, for colleagues in academia, industry and governmental agencies, and for teaching students in biostatistics, epidemiology, clinical trials and medical ethics. No other text has as extensive a collection of cases which provide insight into the many issues, often conflicting, that must be examined before recommendations to continue or discontinue a trial can be made. While depth in statistical methods is not required, some familiarity with statistical design and analysis issues in clinical trials is helpful. The cases cover trials which were terminated early for convincing evidence of benefit, or for harmful effects. Cases with complex issues are also included. This series of cases should provide broad background information for potential monitoring committee members and better prepare them for the challenges that may exist in the trials for which they are responsible. The three editors have contributed two overview chapters as well as several case studies to go along with cases contributed by a distinguished group of colleagues experienced in the design, monitoring and analysis of clinical trials. Dr. David DeMets is currently Professor and Chair, Department of Biostatistics and Medical Informatics at the University of Wisconsin-Madison. He is past president of the Eastern North American Region (ENAR) of the International Biometric Society, a past member of the Board of Directors of the American Statistical Association and an elected Fellow. He recently received the Robert Gordon Lectureship Award, given by the National Institutes of Health, for significant contributions to the field of clinical trials. Dr. Curt Furberg, is currently Professor (and former Chair) of the Department of Public Health Sciences at Wake Forest University. Previously, he was Head of the Clinical Trials Branch and Associate Director of the Clinical Applications and Prevention Program at the National Heart, Lung, and Blood Institute. Dr. Lawrence Friedman is a former Director of the Division of Epidemiology and Clinical Applications and a former Assistant Director for Ethics and Clinical Research at the National Heart, Lung, and Blood Institute. All three are past presidents of the Society of Clinical Trials. The editors have collaborated previously as coauthors of a text: the Fundamentals of Clinical Trials.

Listing 1 - 10 of 31 << page
of 4
>>
Sort by